Financhill
Back

Leap Therapeutics Stock Predictions

Leap Therapeutics Stock Forecast

  • Is Leap Therapeutics Stock Undervalued?
    The current Leap Therapeutics [LPTX] share price is $0.39. The Score for LPTX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • LPTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Leap Therapeutics Stock Go Up Next Year?

Data Unavailable

Leap Therapeutics Stock Rating

Data Unavailable

Leap Therapeutics Stock Price History

Is LPTX stock going to rise?

  • The current trend is relatively stagnant and LPTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
leaptx.com

52-Week Data

52-Week High:
4.79
52-Week Low:
0.39

Prediction Charts

Market Cap:
14.9M
Price in USD:
0.39
Volume:
296.7K
Beta:
0.61

Technical Analysis

SMA50:
1.07
SMA100:
2.11
SMA200:
2.25
52-Wk Change:
-84.52%

Stock Predictions

  • Is Leap Therapeutics stock public?
    Yes, Leap Therapeutics is a publicly traded company.
  • What is the Leap Therapeutics stock quote today?
    The Leap Therapeutics stock price is 0.39 USD today.
  • How to buy Leap Therapeutics stock online?
    You can buy Leap Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-4 0.42 0.44 0.44 0.40
Mar-5 0.43 0.43 0.44 0.42
Mar-6 0.43 0.44 0.45 0.43
Mar-7 0.43 0.44 0.45 0.43
Mar-11 0.42 0.42 0.42 0.40
Mar-12 0.40 0.40 0.42 0.39
Mar-13 0.40 0.39 0.42 0.39
Mar-14 0.40 0.40 0.42 0.39
Mar-17 0.41 0.42 0.45 0.41
Mar-18 0.43 0.41 0.43 0.41
Mar-19 0.41 0.42 0.44 0.41
Mar-20 0.42 0.41 0.44 0.41
Mar-21 0.41 0.40 0.41 0.39
Mar-24 0.41 0.39 0.41 0.39

Leap Therapeutics Earnings

Data Unavailable

Leap Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.04 per share.

* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.